Fidelity Investments’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$111K Sell
21,176
-257,116
-92% -$5.9M ﹤0.01% 3974
2026
Q2
$12.2M Buy
278,292
+196,897
+242% +$7.88M ﹤0.01% 2051
2026
Q1
$3.26M Buy
81,395
+81,011
+21,097% +$3.09M ﹤0.01% 2456
2025
Q4
$15.8K Buy
384
+150
+64% +$5.69K ﹤0.01% 4569
2025
Q3
$6.88K Buy
+234
New +$5.09K ﹤0.01% 4704

Other funds holding SION

Fidelity Investments's SION Position: Q3 2026 in Review

Fidelity Investments reduced its Sionna Therapeutics (SION) stake by 92% in Q3 2026, selling an estimated $5.9M and leaving 21,176 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #3974.

Fidelity Investments first reported a position in SION in Q3 2025 and has held it in 5 quarters since. The position peaked at $12.2M in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Fidelity Investments held 21,176 shares of Sionna Therapeutics worth $111K as of Q3 2026.
  • Fidelity Investments sold 257,116 Sionna Therapeutics shares in Q3 2026, an estimated $5.9M.
  • Sionna Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3974 holding.
  • Fidelity Investments first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Fidelity Investments's Sionna Therapeutics position peaked at $12.2M in Q2 2026.
  • 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.